Gene · 25937
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How do mechanical forces impact macrophages in the processes of mechanosensing and mechanotransduction? | J Zhejiang Univ Sci B | 2025 | 41657064 | PubTator, text mining | PubMed |
| Macrophage Plasticity and Regulatory Networks During the Transition from Inflammation to Fibrosis in the Kidney. | Life (Basel) | 2025 | 41598208 | PubTator, text mining | PubMed |
| The Critical Role of Transcription Factor RUNX2 in Bone Mechanobiology. | Cells | 2025 | 41511334 | PubTator, text mining | PubMed |
| Harnessing the mechanical microenvironment to optimize mesenchymal stem/stromal cells (MSCs) extracellular vesicle therapeutics. | Ann Transl Med | 2025 | 41502443 | PubTator, text mining | PubMed |
| Hippo Signaling Transduction Pathway Deregulation in Eye Diseases. | Maedica (Bucur) | 2025 | 41403814 | PubTator, text mining | PubMed |
| A novel bispecific siRNA concept: Efficient dual knockdown of YAP1 and WWTR1 with a single guide strand. | Mol Ther Nucleic Acids | 2025 | 41341748 | PubTator, text mining | PubMed |
| Stem cells in space: microgravity effects on stem cell fate and implications for regenerative medicine. | NPJ Microgravity | 2025 | 41331262 | PubTator, text mining | PubMed |
| YAP/TAZ deletion in vascular smooth muscle cells mirrors atherosclerosis-associated transcriptional programs. | J Mol Cell Cardiol Plus | 2025 | 41246212 | PubTator, text mining | PubMed |
Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study. | Eur J Cancer | 2025 | 41218239 | PubTator, text mining | PubMed |
| The role of TEAD4 gene in the Hippo signaling pathway in triple-negative breast cancer and targeted therapy strategies. | BMC Med Genomics | 2025 | 41168787 | PubTator, text mining | PubMed |
| C6orf223 promotes colorectal cancer growth and metastasis by facilitating PRMT5-MEP50 multiprotein complex assembling. | J Clin Invest | 2025 | 41090362 | PubTator, text mining | PubMed |
| Pulmonary epithelioid haemangioendothelioma: A comprehensive review of clinical and molecular advances. | Clinics (Sao Paulo) | 2025 | 41086575 | PubTator, text mining | PubMed |
| MiR-376a-3p inhibits bone repair by regulating osteoblastic differentiation. | J Orthop Surg Res | 2025 | 41084006 | PubTator, text mining | PubMed |
| Bending the rules: curvature's impact on cell biology. | BMC Biol | 2025 | 41053697 | PubTator, text mining | PubMed |
| HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks. | Viruses | 2025 | 41012596 | PubTator, text mining | PubMed |
| Mechanotransduction-Mediated Expansion of Rabbit Vocal Fold Epithelial Cells via ROCK Inhibition and Stromal Cell-Derived Paracrine Signals. | Cells | 2025 | 41002379 | PubTator, text mining | PubMed |
| The Hippo Pathway in Kidney Development. | Encyclopedia (Basel, 2021) | 2025 | 40995382 | PubTator, text mining | PubMed |
| Case Report: The first account of primary myeloid sarcoma of the testis combined with ipsilateral epididymal epithelioid hemangioendothelioma. | Front Med (Lausanne) | 2025 | 40978723 | PubTator, text mining | PubMed |
| Role of intratumoral heterogeneity in metastatic progression and drug resistance. | Discov Oncol | 2025 | 40965714 | PubTator, text mining | PubMed |
| AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth. | Cancers (Basel) | 2025 | 40940986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25937/papers?page=4